Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient
Gupta, R.; Wu, J.J.; Levin, E.; Koo, J.Y.M.; Liao, W.
Journal of Drugs in Dermatology Jdd 12(10): 1089
2013
ISSN/ISBN: 1545-9616 PMID: 24085041 Document Number: 14129
Document emailed within 1 workday
Related Documents
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
2005: Pregabalin: new drug. Very similar to gabapentin Prescrire international 14(80): 203-206
Paul, J. 2004: Bullous pemphigoid in a patient with psoriasis and possible drug reaction: a case report Connecticut Medicine 68(10): 611-615
Mishra, V.; Daniel, R.C.; Elmets, C.A.; Levin, A.; Elewski, B.E. 2013: Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy Journal of Drugs in Dermatology: Jdd 12(1): 16-17
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Davidson, K.W.; Kahn, A.; Price, R.D. 1987: Reduction of adverse drug reactions by computerized drug interaction screening Journal of Family Practice 25(4): 371-375
Hahn, M.; Braus, D.F. 2012: Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention Versicherungsmedizin 64(3): 127-131
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Yasuda, K.; Tsurumi, K.; Fujimura, H. 1986: Study of drug interaction between the new antiallergic drug 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and theophylline Arzneimittel-Forschung 36(11): 1642-1646
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089
Greenlaw, C.W.; Zellers, D.D. 1978: Computerized drug-drug interaction screening system American Journal of Hospital Pharmacy 35(5): 567-570
Arneson, H.T.; Colton, R.S. 1987: Drug-drug interaction with the use of antirheumatic drugs Minnesota Medicine 70(10): 589; 592
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Pleasants, R.A.; Kessler, J.M. 1993: Drug allergies, adverse drug reactions, and the patient record American Journal of Hospital Pharmacy 50(7): 1363
Schwabe, U. 1980: The influence of the drug legislation on drug information for the physician and patient Der Internist 21(6): 311-317
Ghate, J.V.; Alspaugh, C.D. 2009: Adalimumab in the management of palmoplantar psoriasis Dermatology Online Journal 15(7): 15
Noiles, K.; Vender, R. 2008: Treatment of severe facial psoriasis with adalimumab Journal of Drugs in Dermatology: Jdd 7(12): 1165-1167
Glenn, C.J.; Kobraei, K.B.; Russo, J.J. 2011: New-onset psoriasis associated with adalimumab: a report of two cases Dermatology Online Journal 17(9): 15
Maejima, H.; Katayama, C.; Watarai, A.; Nishiyama, H.; Katsuoka, K. 2012: A case of psoriasis verrucosa successfully treated with adalimumab Journal of Drugs in Dermatology: Jdd 11(11): E74-E75